Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,17130,687,1.10 [0.91-1.34],0.3169430504942092
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16596,191,1.46 [1.08-1.97],0.0129197830212708
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,18933,117,1.19 [0.78-1.82],0.4240589429539403
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12766,645,1.23 [1.01-1.49],0.0355817619139515
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18897,81,1.17 [0.69-1.97],0.570046442807266
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17210,67,1.47 [0.92-2.35],0.1100637287350743
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19772,80,1.11 [0.64-1.93],0.7126364760726496
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19782,55,0.29 [0.09-0.92],0.0356500691894214
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16864,44,1.00 [0.44-2.24],0.9955952066429112
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,18982,96,1.42 [0.96-2.10],0.075914839902207
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other septicaemia,18948,62,1.46 [0.91-2.35],0.1147975039860502
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19834,50,0.65 [0.25-1.69],0.3753172706162919
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19865,58,0.96 [0.48-1.93],0.9188244469372572
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19859,52,0.93 [0.44-1.99],0.8610115837618169
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Mycoses,19592,34,1.10 [0.48-2.56],0.8201454439669017
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",18810,320,1.22 [0.94-1.58],0.1374044709057963
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18612,122,1.20 [0.79-1.81],0.3952628332762457
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18709,219,1.27 [0.94-1.71],0.1269083137726223
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",15531,64,1.56 [0.99-2.47],0.0563825030027814
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15505,38,1.26 [0.62-2.54],0.5259561592638793
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15686,219,1.10 [0.78-1.55],0.568749906895887
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15692,225,1.13 [0.82-1.58],0.4523602934583816
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",15656,189,0.94 [0.62-1.44],0.7838056793525834
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",15510,43,1.01 [0.45-2.27],0.9882673168110248
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,17693,435,1.35 [1.10-1.65],0.004097702383931
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",18571,315,1.14 [0.86-1.50],0.3686187823597929
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19330,107,1.11 [0.69-1.79],0.661978905382982
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19893,112,1.34 [0.90-1.99],0.1499126883769504
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Rectum,19607,62,1.11 [0.59-2.06],0.7486666263352124
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19904,54,1.09 [0.54-2.17],0.8165525353901681
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Stomach,19942,38,1.32 [0.66-2.64],0.4332760226201623
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm,19666,262,1.24 [0.94-1.63],0.1290977013580405
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19911,92,1.08 [0.64-1.82],0.7728842445132074
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19917,62,1.28 [0.74-2.20],0.3732994933159186
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19880,30,1.41 [0.69-2.88],0.3516362354449438
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma, any site",19883,30,1.41 [0.69-2.88],0.3514093944390978
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi,19814,104,1.55 [1.12-2.14],0.0086917238377783
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,19931,43,1.12 [0.55-2.29],0.7526706878863361
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Other benign neoplasms of skin,19837,107,0.99 [0.60-1.65],0.9818601436767624
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,18982,92,1.43 [0.95-2.16],0.0848881914506357
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,18675,192,1.40 [1.05-1.86],0.0234678120009361
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,18675,192,1.40 [1.05-1.86],0.0234678120009361
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),16828,408,1.29 [1.03-1.62],0.0289836986794494
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19515,34,0.43 [0.11-1.63],0.2119945928318488
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19730,50,1.91 [1.30-2.79],0.0008821171608462
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,15651,1154,1.08 [0.91-1.28],0.3804798930864118
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19370,154,0.98 [0.63-1.54],0.9370697696003836
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,17591,107,1.50 [1.03-2.18],0.0333294064422062
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18818,141,1.22 [0.80-1.84],0.3531551326721471
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17580,96,1.59 [1.10-2.31],0.0148115696847026
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,18043,559,1.12 [0.89-1.42],0.3415813117195263
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,18027,543,1.13 [0.90-1.44],0.2949612324673955
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,18487,140,1.20 [0.73-1.99],0.4657316627520061
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",18487,139,1.22 [0.74-2.00],0.4326485161260844
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,15531,1034,1.06 [0.89-1.27],0.509314048666882
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",14640,143,1.07 [0.67-1.70],0.7750976630208531
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,15449,952,1.06 [0.88-1.28],0.5223166650639887
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,14537,40,1.84 [1.15-2.96],0.0113431939774261
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14571,74,1.57 [1.02-2.40],0.0384109842636053
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Any mental disorder,16959,577,1.20 [0.98-1.48],0.0794679469047797
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16677,295,0.95 [0.67-1.34],0.7594046239625375
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19475,225,1.00 [0.69-1.47],0.9859098058549866
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19545,173,1.06 [0.69-1.61],0.8017817354750852
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,18171,69,1.06 [0.56-1.98],0.8625597245271612
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",19824,69,1.05 [0.55-2.00],0.8896244182538555
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",16451,69,1.07 [0.57-2.00],0.841028778249163
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Alcohol dependence,18201,99,1.13 [0.67-1.90],0.6552370193057497
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Smoking dependency,18188,74,1.07 [0.58-1.99],0.8324589393807877
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16442,60,1.60 [1.06-2.42],0.0263833889640621
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16596,214,1.21 [0.89-1.66],0.2259512747289636
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Depression,18956,181,1.14 [0.80-1.64],0.467988923255707
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Depression or dysthymia,16376,160,1.17 [0.80-1.69],0.4178002688292516
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16467,85,1.37 [0.89-2.11],0.148308689491928
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Other anxiety disorders,19102,45,1.09 [0.50-2.35],0.83316350145841
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Neurological diseases,17016,1101,1.08 [0.92-1.27],0.3534189831089299
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15341,77,1.64 [1.15-2.34],0.0061991650071173
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19855,56,1.62 [1.07-2.47],0.0232864826439604
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,18840,440,1.07 [0.84-1.37],0.5764105439572174
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Epilepsy,18539,139,0.74 [0.43-1.28],0.2868965082957263
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Migraine,18426,26,0.38 [0.08-1.86],0.2354063240841746
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19815,19,0.76 [0.17-3.28],0.7078799471632495
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19157,80,1.59 [1.08-2.32],0.0176160299804067
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other sleep disorders,18590,190,1.19 [0.83-1.69],0.3417071983488947
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Sleep apnoea,19338,151,1.28 [0.88-1.86],0.2010668159513629
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19145,392,0.91 [0.68-1.23],0.5509261030208583
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18856,103,1.04 [0.63-1.72],0.8752407454079677
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18939,186,0.76 [0.47-1.22],0.2607323852562389
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19674,75,1.41 [0.90-2.19],0.1311929861943704
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Hemiplegia,19649,50,1.42 [0.82-2.45],0.2085527056053355
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other neurological diseases,19532,100,0.97 [0.56-1.68],0.9210697804054588
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19446,264,1.04 [0.75-1.43],0.8153126539813091
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19332,150,0.89 [0.56-1.43],0.6348096559877348
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19250,68,1.21 [0.72-2.04],0.4634829673547398
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19268,86,0.79 [0.40-1.53],0.481721569379324
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19219,37,1.20 [0.57-2.54],0.6352160714619716
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17471,118,1.21 [0.79-1.87],0.3739012377453637
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17674,321,1.21 [0.93-1.58],0.1479276433191025
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19122,188,1.08 [0.75-1.57],0.6782791422417006
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19595,41,1.49 [0.78-2.83],0.2236863668200045
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2168,41,1.27 [0.64-2.53],0.496233792324114
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",17468,41,1.60 [0.84-3.05],0.1511518292713984
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19398,80,1.46 [0.94-2.25],0.0901756692503131
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19360,42,1.38 [0.73-2.59],0.3226104998144378
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19489,62,0.82 [0.39-1.76],0.616262522102168
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19525,81,0.48 [0.20-1.12],0.0875791046559515
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,19869,116,0.58 [0.30-1.14],0.1158169104554375
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,19180,88,1.56 [1.07-2.26],0.0210261953059897
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,13431,3059,1.17 [1.04-1.32],0.0081275784617562
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19378,50,1.31 [0.74-2.34],0.353574113337411
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, essential",14211,1988,1.20 [1.05-1.36],0.0079296105621352
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertension,14238,2015,1.21 [1.06-1.38],0.0044944640510457
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12286,63,2.01 [1.42-2.83],7.478313094117664e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",17678,1351,1.19 [1.03-1.38],0.0192872909496804
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Angina pectoris,17075,748,1.14 [0.94-1.39],0.1816241796993173
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18735,263,1.18 [0.87-1.61],0.2862776348035216
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19063,591,1.10 [0.88-1.36],0.4102519969249176
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19768,138,1.05 [0.67-1.64],0.828721447882891
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16740,413,1.15 [0.89-1.48],0.282713700943655
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,17456,1150,1.23 [1.06-1.44],0.0075323229827748
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19211,104,1.16 [0.72-1.86],0.5492302571766441
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19316,210,1.10 [0.78-1.56],0.5917526302363298
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19185,78,0.95 [0.50-1.81],0.881627167297155
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19186,79,0.96 [0.51-1.81],0.8952118246577371
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12298,75,0.99 [0.54-1.83],0.97682016994467
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15676,66,1.17 [0.64-2.15],0.6113119387326229
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Conduction disorders,15745,135,1.44 [1.01-2.07],0.0457271368707911
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9921,110,1.63 [1.13-2.33],0.0081996617831433
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10311,500,1.22 [0.96-1.55],0.0987949019327574
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other arrhythmias,15682,72,1.69 [1.12-2.54],0.0118772999319148
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15718,108,1.25 [0.80-1.97],0.3282553217275306
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Heart failure, strict",18867,264,1.23 [0.92-1.66],0.1638429140162642
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19105,145,1.15 [0.76-1.72],0.5040792956849824
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19128,133,1.12 [0.72-1.73],0.609973448281224
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19194,117,1.11 [0.69-1.78],0.6592574920644423
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18787,68,1.23 [0.70-2.18],0.4737401275406524
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18845,126,1.10 [0.69-1.75],0.6956173235812185
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18845,132,1.09 [0.70-1.70],0.706954635184222
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18829,116,1.09 [0.68-1.75],0.7118224103190506
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19751,109,1.14 [0.71-1.82],0.5862290910634971
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Varicose veins,18990,277,1.01 [0.74-1.39],0.93484574428213
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypotension,18909,64,1.24 [0.70-2.21],0.4613501649792172
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,15591,1705,1.13 [0.99-1.28],0.064855540529789
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19804,73,0.81 [0.39-1.67],0.5715978613660047
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Influenza and pneumonia,18227,211,1.45 [1.10-1.90],0.0076206059681552
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",18194,178,1.48 [1.11-1.97],0.0076560838412791
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19156,235,1.04 [0.74-1.47],0.821796910718466
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19154,233,1.06 [0.75-1.49],0.7475350432807212
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19205,551,0.98 [0.77-1.23],0.8391187061480962
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic sinusitis,18718,64,1.09 [0.59-2.01],0.7897770120865512
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Nasal polyp,18792,138,0.72 [0.42-1.25],0.2455201043599835
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19006,352,0.99 [0.74-1.31],0.9305657723843948
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Deviated nasal septum,18844,190,0.82 [0.53-1.26],0.3597337979517681
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8699,49,1.33 [0.71-2.48],0.3671678297423322
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,17822,728,1.09 [0.90-1.32],0.3873869147857766
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Early onset COPD,18841,163,1.00 [0.64-1.56],0.9839876242447388
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",18866,188,1.15 [0.79-1.68],0.4571935865408622
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",18866,188,1.15 [0.79-1.68],0.4571935865408622
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",18766,558,1.05 [0.84-1.31],0.6659615246419353
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Asthma,13576,558,1.07 [0.86-1.33],0.5621647365372275
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13287,558,1.07 [0.87-1.34],0.5133242851549769
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13567,549,1.06 [0.85-1.33],0.5871024485910927
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19571,96,1.70 [1.22-2.38],0.0019524864004004
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Interstitial lung disease,18941,75,1.68 [1.15-2.46],0.0074128187414772
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",19640,75,1.69 [1.15-2.48],0.0070577929548777
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18936,70,1.68 [1.13-2.48],0.0100269812768448
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pleural effusion,18003,113,1.50 [1.05-2.14],0.0262305504078607
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of pleura,18129,239,1.31 [0.98-1.74],0.0689938992381114
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,18792,109,1.21 [0.78-1.90],0.3942987545396443
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,13285,4689,1.16 [1.05-1.27],0.0026552817809538
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19548,310,1.23 [0.96-1.58],0.1086469474054877
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19923,63,1.37 [0.86-2.20],0.1883703933999386
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Impacted teeth,19924,60,1.37 [0.84-2.23],0.2021701115264816
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Dental caries,19334,96,1.41 [0.95-2.09],0.0889400652925912
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19306,68,0.71 [0.32-1.56],0.3940674334628234
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19915,72,1.27 [0.79-2.04],0.3286832671569419
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19302,64,0.67 [0.29-1.55],0.3541219336314775
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19120,69,1.48 [0.95-2.30],0.0843958444030264
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19873,51,1.50 [0.91-2.47],0.1128680416616416
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15313,268,1.34 [1.02-1.75],0.0353948737552713
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",16728,1683,1.14 [1.00-1.29],0.0522988476932224
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophagitis,15374,329,1.21 [0.94-1.57],0.143252435221241
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15600,555,1.17 [0.95-1.45],0.1285250660617484
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15112,67,0.93 [0.46-1.86],0.8310190818576507
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15288,243,1.12 [0.81-1.55],0.4838437670737615
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15109,64,0.93 [0.45-1.90],0.8429409339230323
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastric ulcer,15169,124,1.38 [0.94-2.03],0.1018063943839647
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Duodenal ulcer,15197,152,1.35 [0.95-1.92],0.0919414271079474
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19801,105,1.04 [0.62-1.75],0.8745294167222426
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Chronic gastritis,15147,102,1.20 [0.74-1.93],0.4608710725260674
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15696,651,1.04 [0.84-1.29],0.7107854741029735
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of appendix,19814,86,0.69 [0.34-1.39],0.2963716867954772
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Functional dyspepsia,15287,242,1.22 [0.91-1.64],0.1799418294182265
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15187,142,0.82 [0.48-1.38],0.44843058095771
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19775,148,1.45 [1.06-1.99],0.0190518867542188
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute appendicitis,19795,67,0.59 [0.25-1.38],0.2204806800446633
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Hernia,17030,1718,1.02 [0.89-1.17],0.7611716736750886
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Inguinal hernia,16266,954,0.91 [0.76-1.11],0.3623161527865051
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Umbilical hernia,15457,145,1.22 [0.82-1.81],0.3318743264038094
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ventral hernia,15390,78,1.53 [1.01-2.33],0.0459268230234469
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,15954,642,1.07 [0.86-1.32],0.5583348095691452
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19221,511,1.25 [1.02-1.52],0.0281466425089607
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestines,15418,1518,1.12 [0.98-1.28],0.103876849047876
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19661,45,1.54 [0.94-2.52],0.088746706657116
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",19882,58,1.38 [0.84-2.27],0.2031084975268894
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn disease,18768,58,1.40 [0.85-2.29],0.1850680806279451
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18756,46,1.54 [0.94-2.53],0.0869130149068769
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",19837,120,1.24 [0.83-1.85],0.2866634625225022
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcerative colitis,18830,120,1.25 [0.84-1.86],0.2672801021078743
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18818,108,1.29 [0.86-1.93],0.2273703451456418
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19101,391,1.16 [0.91-1.47],0.2359071012240325
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19099,389,1.16 [0.91-1.47],0.2385213144518774
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13982,82,1.23 [0.76-1.98],0.4088180422855254
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal stricture,19569,82,1.24 [0.76-2.02],0.3876763668035705
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",13958,58,1.37 [0.82-2.30],0.2331125274891355
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,14334,434,1.15 [0.91-1.45],0.241220952701806
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,13978,78,1.29 [0.82-2.05],0.2738212900317525
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14049,149,1.29 [0.91-1.82],0.1549506759536214
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Constipation,18674,137,1.28 [0.89-1.85],0.1818164306865601
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19624,44,1.23 [0.62-2.42],0.5564734454474753
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14041,141,1.43 [1.04-1.96],0.0261032538441083
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,13983,83,1.14 [0.68-1.90],0.6242914872395926
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,14634,734,1.02 [0.84-1.25],0.8056321594209701
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestine,14162,262,1.12 [0.83-1.52],0.4510682337955488
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19613,33,1.25 [0.58-2.68],0.5714267373286699
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of liver,19229,121,1.26 [0.84-1.90],0.2558701774530194
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of liver,19178,70,1.13 [0.63-2.04],0.6773466452684396
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18960,296,1.41 [1.11-1.78],0.0042614638691247
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholelithiasis,18876,212,1.42 [1.08-1.86],0.0129071539049832
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholecystitis,18716,52,1.19 [0.62-2.28],0.5973715402571803
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18686,22,nan [nan-nan],
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute pancreatitis,18722,58,1.51 [0.95-2.40],0.084033567782026
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),19773,58,1.50 [0.94-2.39],0.0900384082808408
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of the digestive system,18771,269,1.15 [0.86-1.55],0.344051294881975
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18530,28,0.97 [0.35-2.68],0.956969931196858
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Coeliac disease,18523,21,1.39 [0.60-3.21],0.4393190941107243
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18552,50,1.55 [0.95-2.54],0.0801720504789761
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,18699,197,1.08 [0.75-1.56],0.6605053867028129
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,GI-bleeding,18697,195,1.10 [0.77-1.58],0.58935303518126
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,17345,1263,1.09 [0.94-1.26],0.2464032012555174
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19569,85,1.16 [0.70-1.94],0.5664524687221232
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19632,382,1.07 [0.83-1.38],0.6162072675987968
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,18627,391,0.97 [0.73-1.28],0.8313512832510224
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19104,397,0.96 [0.73-1.27],0.7800155953832352
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18796,89,1.11 [0.66-1.87],0.691446848004587
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,18957,250,0.94 [0.66-1.34],0.744608001977046
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19717,79,1.61 [1.11-2.35],0.0129947994008971
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19703,65,1.69 [1.15-2.49],0.0082159594247902
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19689,51,1.61 [1.01-2.59],0.0468875278285051
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19682,41,1.63 [1.00-2.67],0.0496719630145197
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19681,40,1.65 [1.01-2.70],0.0437112192372382
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19296,46,1.09 [0.54-2.21],0.8087393585715809
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19562,312,1.04 [0.78-1.40],0.7659293130839872
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18312,76,0.60 [0.27-1.35],0.2203233726591223
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18273,37,0.43 [0.12-1.58],0.2031743723630404
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18271,35,0.43 [0.11-1.62],0.2108275591879375
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18391,155,0.94 [0.60-1.47],0.787480013814438
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18377,141,1.00 [0.64-1.57],0.9976861405445544
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,14749,2965,1.07 [0.96-1.20],0.1928582746880494
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,15973,1751,1.04 [0.91-1.20],0.5307907804888804
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18051,909,0.98 [0.81-1.18],0.8159333541501725
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14292,70,1.57 [1.03-2.40],0.037320394506252
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14552,330,1.33 [1.04-1.71],0.021549633152692
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19710,67,1.64 [1.08-2.48],0.0200517085677245
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19713,58,1.73 [1.14-2.61],0.0099742377090527
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,15106,884,1.02 [0.84-1.24],0.8306071522868805
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",17152,884,0.98 [0.81-1.19],0.8411346720736175
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14331,109,1.27 [0.81-1.99],0.3014969198657311
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19159,105,1.28 [0.81-2.01],0.28576747379325
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,14350,128,1.02 [0.63-1.66],0.921257009012019
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14266,44,0.89 [0.36-2.22],0.8083064198055503
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14440,218,1.07 [0.75-1.54],0.6977903235827694
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19833,107,1.05 [0.63-1.75],0.8392473939468024
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,14703,481,0.96 [0.73-1.25],0.7355737330906202
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14462,240,1.16 [0.84-1.61],0.3581621113869857
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15199,977,0.93 [0.77-1.12],0.4315284527089762
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14242,20,0.88 [0.23-3.39],0.8546485189854337
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14263,41,1.14 [0.53-2.46],0.742619471259276
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14243,21,0.95 [0.28-3.24],0.9311001618670164
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14235,13,0.11 [0.01-1.46],0.0935610864032003
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14721,499,0.86 [0.66-1.12],0.2578603270932738
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14659,437,0.81 [0.61-1.08],0.1571431593640805
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16129,217,1.02 [0.71-1.46],0.934145477023704
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19696,35,1.42 [0.75-2.69],0.2772098702105926
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19676,15,1.43 [0.54-3.79],0.4775321770740931
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17462,37,1.41 [0.73-2.70],0.3021720426631834
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17669,244,1.13 [0.82-1.55],0.4657135268856796
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18126,701,1.16 [0.96-1.39],0.1258716591562484
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17566,141,1.38 [0.97-1.96],0.0713635303433876
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17500,75,0.91 [0.46-1.79],0.7898448940055164
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17975,550,1.16 [0.95-1.43],0.1443439561876391
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,17470,45,1.23 [0.64-2.38],0.5352264265162048
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17621,196,1.16 [0.83-1.62],0.3738325601979289
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,17508,83,1.02 [0.58-1.79],0.9466433007772812
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17481,56,1.04 [0.53-2.07],0.9039731753511544
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17525,100,1.07 [0.64-1.79],0.788238908763826
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,17467,42,1.37 [0.75-2.52],0.3048690904536437
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17645,220,1.25 [0.92-1.68],0.150215560209438
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17340,198,1.00 [0.69-1.46],0.9953629749286677
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17193,51,nan [nan-nan],
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17198,56,0.85 [0.38-1.90],0.693584252518888
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17194,52,1.06 [0.53-2.10],0.872091584282965
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17193,51,1.09 [0.56-2.13],0.806305519197949
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17293,151,0.98 [0.63-1.51],0.9125106897470672
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17285,143,1.00 [0.64-1.54],0.985024751065138
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17342,200,0.83 [0.54-1.28],0.4018704853223432
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17186,44,0.44 [0.13-1.42],0.1676697135062129
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17211,69,1.02 [0.53-1.93],0.9631682227092296
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17234,92,0.83 [0.44-1.56],0.5552187064897096
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17179,37,0.87 [0.33-2.27],0.7711372526244903
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17438,296,1.02 [0.75-1.39],0.899419804529465
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17266,124,1.12 [0.72-1.75],0.6049037303273941
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17299,157,0.91 [0.58-1.44],0.6957353229508325
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19100,84,1.28 [0.79-2.08],0.3172158303388211
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19253,237,1.17 [0.86-1.59],0.3095157340573314
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19059,43,1.24 [0.64-2.41],0.525000086430222
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19060,44,0.87 [0.36-2.09],0.7552441853508167
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19092,76,1.05 [0.59-1.88],0.8598260043624606
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,15334,1915,1.17 [1.03-1.32],0.0138791877819471
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,17193,1051,1.14 [0.97-1.33],0.1058303501527165
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,17721,216,1.77 [1.42-2.22],6.304960885107152e-07
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17576,71,1.29 [0.76-2.19],0.3421684902788793
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Acute renal failure,17779,51,1.72 [1.09-2.72],0.0207909678306034
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,17781,53,2.25 [1.64-3.09],4.958807619971827e-07
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17794,66,2.14 [1.58-2.90],1.0561554291952457e-06
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19528,295,1.01 [0.74-1.38],0.9277799831904028
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19520,60,1.97 [1.39-2.80],0.0001542166937202
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19441,208,0.80 [0.52-1.23],0.3041934961916477
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19344,111,1.19 [0.77-1.85],0.4280800125346178
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18127,683,1.07 [0.88-1.31],0.4839014657457913
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Cystitis,17492,48,0.97 [0.43-2.15],0.932703099885992
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17502,58,1.42 [0.85-2.36],0.1774453891021462
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17756,312,1.16 [0.89-1.53],0.277043975894932
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urethral stricture,17558,114,0.95 [0.56-1.60],0.839059430532934
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,17745,301,1.17 [0.89-1.54],0.2677007687447233
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,16613,471,1.05 [0.82-1.34],0.7062017725904397
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16229,87,0.83 [0.43-1.59],0.5722340273870241
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hydrocele,16230,88,1.79 [1.31-2.45],0.0002898256160034
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16274,132,1.10 [0.71-1.69],0.6756324960567855
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16274,132,1.14 [0.75-1.75],0.5403154593807251
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16313,171,1.22 [0.87-1.72],0.2519982188321789
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19528,58,1.01 [0.50-2.03],0.9825827481430752
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Falls/tendency to fall,18179,461,0.89 [0.68-1.17],0.4155988314202226
